SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'SIA'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1A4G_A_ZMRA466_1 (NEURAMINIDASE) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 6 / 12 | ARG A 266ASP A 291GLU A 539ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 (-2.8A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.47A | 1a4gA-2bf6A:25.0 | 1a4gA-2bf6A:22.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1A4G_B_ZMRB466_1 (NEURAMINIDASE) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 5 / 12 | ARG A 266GLU A 539ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.37A | 1a4gB-2bf6A:24.9 | 1a4gB-2bf6A:22.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1D8C_A_SORA4000_0 (MALATE SYNTHASE G) |
4mbz | MAJOR CAPSID PROTEINVP1 (Africangreenmonkeypolyomavirus) | 3 / 3 | GLN A 130HIS A 271PRO A 144 | SIA A 406 (-4.3A)SIA A 406 (-4.2A)None | 0.90A | 1d8cA-4mbzA:undetectable | 1d8cA-4mbzA:17.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1FKO_A_EFZA999_1 (HIV-1 RT, A-CHAIN) |
4kps | HEMAGGLUTININ (InfluenzaAvirus) | 5 / 10 | ASN A 150VAL A 67GLY A 68TRP A 153LEU A 252 | NoneNoneNoneSIA A 801 (-3.6A)None | 1.22A | 1fkoA-4kpsA:undetectable | 1fkoA-4kpsA:20.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1NNC_A_ZMRA479_1 (NEURAMINIDASE N9) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 5 / 12 | ARG A 266GLU A 539ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.51A | 1nncA-2bf6A:21.1 | 1nncA-2bf6A:21.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1P6K_A_MTLA870_0 (NITRIC-OXIDESYNTHASE, BRAIN) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 4 / 8 | ARG A 517ASN A 514GLN A 493ASN A 562 | NoneNoneSIA A1692 (-3.0A)None | 1.15A | 1p6kA-2bf6A:undetectable | 1p6kA-2bf6A:22.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1P6K_B_MTLB871_0 (NITRIC-OXIDESYNTHASE, BRAIN) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 4 / 8 | ARG A 517ASN A 514GLN A 493ASN A 562 | NoneNoneSIA A1692 (-3.0A)None | 1.08A | 1p6kB-2bf6A:undetectable | 1p6kB-2bf6A:22.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1Q23_J_FUAJ711_1 (CHLORAMPHENICOLACETYLTRANSFERASE) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 5 / 11 | PHE A 341PHE A 460LEU A 461VAL A 453VAL A 484 | NoneSIA A1692 ( 4.9A)NoneNoneNone | 1.35A | 1q23J-2bf6A:undetectable | 1q23J-2bf6A:16.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1QZZ_A_ACTA421_0 (ACLACINOMYCIN-10-HYDROXYLASE) |
2w68 | SIALIDASE (Vibriocholerae) | 5 / 8 | GLY A 70GLY A 202GLY A 106MET A 107SER A 197 | NoneNoneNoneSIA A1217 ( 4.7A)SIA A1217 (-3.7A) | 1.15A | 1qzzA-2w68A:undetectable | 1qzzA-2w68A:19.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RS6_A_MTLA870_0 (NITRIC-OXIDESYNTHASE, BRAIN) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 4 / 8 | ARG A 517ASN A 514GLN A 493ASN A 562 | NoneNoneSIA A1692 (-3.0A)None | 1.20A | 1rs6A-2bf6A:undetectable | 1rs6A-2bf6A:22.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RS6_B_MTLB871_0 (NITRIC-OXIDESYNTHASE, BRAIN) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 4 / 8 | ARG A 517ASN A 514GLN A 493ASN A 562 | NoneNoneSIA A1692 (-3.0A)None | 1.09A | 1rs6B-2bf6A:undetectable | 1rs6B-2bf6A:22.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RS7_B_MTLB871_0 (NITRIC-OXIDESYNTHASE, BRAIN) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 4 / 8 | ARG A 517ASN A 514GLN A 493ASN A 562 | NoneNoneSIA A1692 (-3.0A)None | 1.05A | 1rs7B-2bf6A:undetectable | 1rs7B-2bf6A:22.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1V3E_B_ZMRB2200_1 (HEMAGGLUTININ-NEURAMINIDASE GLYCOPROTEIN) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 5 / 10 | ARG A 266TYR A 485GLU A 539ARG A 555ARG A 615 | SIA A1692 (-2.7A)SIA A1692 (-4.7A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-3.1A) | 0.72A | 1v3eB-2bf6A:9.2 | 1v3eB-2bf6A:24.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1V3E_B_ZMRB2200_1 (HEMAGGLUTININ-NEURAMINIDASE GLYCOPROTEIN) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 5 / 10 | ARG A 266TYR A 485GLU A 539ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 (-4.7A)SIA A1692 ( 3.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.85A | 1v3eB-2bf6A:9.2 | 1v3eB-2bf6A:24.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1Z11_B_8MOB501_0 (CYTOCHROME P450,FAMILY 2, SUBFAMILYA, POLYPEPTIDE 6) |
2wbv | FIBER PROTEIN (CaninemastadenovirusA) | 5 / 11 | PHE A 516VAL A 411PHE A 519GLY A 404ILE A 377 | NoneNoneNoneNoneSIA A1545 ( 4.3A) | 1.04A | 1z11B-2wbvA:undetectable | 1z11B-2wbvA:18.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ZZQ_A_MTLA870_0 (NITRIC-OXIDESYNTHASE, BRAIN) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 4 / 8 | ARG A 517ASN A 514GLN A 493ASN A 562 | NoneNoneSIA A1692 (-3.0A)None | 1.17A | 1zzqA-2bf6A:undetectable | 1zzqA-2bf6A:20.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ZZQ_B_MTLB871_0 (NITRIC-OXIDESYNTHASE, BRAIN) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 4 / 8 | ARG A 517ASN A 514GLN A 493ASN A 562 | NoneNoneSIA A1692 (-3.0A)None | 1.10A | 1zzqB-2bf6A:undetectable | 1zzqB-2bf6A:20.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ZZU_B_MTLB871_0 (NITRIC-OXIDESYNTHASE, BRAIN) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 4 / 8 | ARG A 517ASN A 514GLN A 493ASN A 562 | NoneNoneSIA A1692 (-3.0A)None | 1.09A | 1zzuB-2bf6A:undetectable | 1zzuB-2bf6A:20.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2CML_A_ZMRA1477_1 (NEURAMINIDASE) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 6 / 12 | ARG A 266ASP A 291GLU A 539ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 (-2.8A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.50A | 2cmlA-2bf6A:21.3 | 2cmlA-2bf6A:22.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_A_ZMRA1478_1 (NEURAMINIDASE) |
4h53 | NEURAMINIDASE (InfluenzaAvirus) | 5 / 7 | SER A 367SER A 370SER A 372ASN A 400TRP A 403 | SIA A 510 (-2.5A)SIA A 510 (-2.6A)SIA A 510 (-2.8A)SIA A 510 (-3.4A)SIA A 510 (-3.5A) | 0.72A | 2cmlA-4h53A:64.8 | 2cmlA-4h53A:51.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2CML_B_ZMRB2477_1 (NEURAMINIDASE) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 6 / 12 | ARG A 266ASP A 291GLU A 539ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 (-2.8A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.50A | 2cmlB-2bf6A:3.0 | 2cmlB-2bf6A:22.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_B_ZMRB2478_1 (NEURAMINIDASE) |
4h53 | NEURAMINIDASE (InfluenzaAvirus) | 5 / 8 | SER A 367SER A 370SER A 372ASN A 400TRP A 403 | SIA A 510 (-2.5A)SIA A 510 (-2.6A)SIA A 510 (-2.8A)SIA A 510 (-3.4A)SIA A 510 (-3.5A) | 0.48A | 2cmlB-4h53A:64.7 | 2cmlB-4h53A:51.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2CML_C_ZMRC3477_1 (NEURAMINIDASE) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 6 / 12 | ARG A 266ASP A 291GLU A 539ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 (-2.8A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.53A | 2cmlC-2bf6A:21.5 | 2cmlC-2bf6A:22.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_C_ZMRC3478_1 (NEURAMINIDASE) |
4h53 | NEURAMINIDASE (InfluenzaAvirus) | 5 / 8 | SER A 367SER A 370SER A 372ASN A 400TRP A 403 | SIA A 510 (-2.5A)SIA A 510 (-2.6A)SIA A 510 (-2.8A)SIA A 510 (-3.4A)SIA A 510 (-3.5A) | 0.76A | 2cmlC-4h53A:64.7 | 2cmlC-4h53A:51.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2CML_D_ZMRD4477_1 (NEURAMINIDASE) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 6 / 12 | ARG A 266ASP A 291GLU A 539ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 (-2.8A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.51A | 2cmlD-2bf6A:21.3 | 2cmlD-2bf6A:22.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_D_ZMRD4478_1 (NEURAMINIDASE) |
4h53 | NEURAMINIDASE (InfluenzaAvirus) | 5 / 8 | SER A 367SER A 370SER A 372ASN A 400TRP A 403 | SIA A 510 (-2.5A)SIA A 510 (-2.6A)SIA A 510 (-2.8A)SIA A 510 (-3.4A)SIA A 510 (-3.5A) | 0.63A | 2cmlD-4h53A:64.7 | 2cmlD-4h53A:51.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2F0Z_A_ZMRA381_1 (SIALIDASE 2) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 6 / 12 | ARG A 266TYR A 485GLU A 539ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 (-4.7A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.40A | 2f0zA-2bf6A:44.2 | 2f0zA-2bf6A:23.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2F10_A_BCZA382_0 (SIALIDASE 2) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 8 / 12 | ARG A 266ILE A 267ARG A 285TYR A 485GLU A 539ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 (-4.5A)SIA A1692 (-3.6A)SIA A1692 (-4.7A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.57A | 2f10A-2bf6A:43.1 | 2f10A-2bf6A:23.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2HTQ_A_ZMRA472_1 (NEURAMINIDASE) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 5 / 12 | ARG A 266GLU A 539ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.64A | 2htqA-2bf6A:12.8 | 2htqA-2bf6A:23.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Y7K_A_SALA1303_1 (LYSR-TYPE REGULATORYPROTEIN) |
5iuc | PLATELET BINDINGPROTEIN GSPB (Streptococcusgordonii) | 4 / 7 | PRO A 474ILE A 520GLY A 450TRP A 453 | NoneNoneSIA A 602 ( 4.1A)None | 0.91A | 2y7kA-5iucA:undetectable | 2y7kA-5iucA:18.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2YA7_A_ZMRA1776_1 (NEURAMINIDASE A) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 5 / 12 | ARG A 266ILE A 267ASP A 283ILE A 297ARG A 615 | SIA A1692 (-2.7A)SIA A1692 (-4.5A)NoneNoneSIA A1692 (-3.1A) | 1.40A | 2ya7A-2bf6A:57.0 | 2ya7A-2bf6A:43.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2YA7_A_ZMRA1776_1 (NEURAMINIDASE A) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 10 / 12 | ARG A 266ILE A 267ASP A 283ILE A 327ASP A 328TYR A 485GLN A 493ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 (-4.5A)NoneSIA A1692 (-4.5A)SIA A1692 (-2.9A)SIA A1692 (-4.7A)SIA A1692 (-3.0A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.35A | 2ya7A-2bf6A:57.0 | 2ya7A-2bf6A:43.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2YA7_A_ZMRA1776_1 (NEURAMINIDASE A) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 5 / 12 | ARG A 285ILE A 267ASP A 328TYR A 485GLN A 493 | SIA A1692 (-3.6A)SIA A1692 (-4.5A)SIA A1692 (-2.9A)SIA A1692 (-4.7A)SIA A1692 (-3.0A) | 1.22A | 2ya7A-2bf6A:57.0 | 2ya7A-2bf6A:43.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2YA7_B_ZMRB1776_1 (NEURAMINIDASE A) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 5 / 12 | ARG A 266ILE A 267ASP A 283ILE A 297ARG A 615 | SIA A1692 (-2.7A)SIA A1692 (-4.5A)NoneNoneSIA A1692 (-3.1A) | 1.38A | 2ya7B-2bf6A:56.7 | 2ya7B-2bf6A:43.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2YA7_B_ZMRB1776_1 (NEURAMINIDASE A) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 10 / 12 | ARG A 266ILE A 267ASP A 283ILE A 327ASP A 328TYR A 485GLN A 493ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 (-4.5A)NoneSIA A1692 (-4.5A)SIA A1692 (-2.9A)SIA A1692 (-4.7A)SIA A1692 (-3.0A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.36A | 2ya7B-2bf6A:56.7 | 2ya7B-2bf6A:43.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2YA7_B_ZMRB1776_1 (NEURAMINIDASE A) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 5 / 12 | ARG A 285ILE A 267ASP A 328TYR A 485GLN A 493 | SIA A1692 (-3.6A)SIA A1692 (-4.5A)SIA A1692 (-2.9A)SIA A1692 (-4.7A)SIA A1692 (-3.0A) | 1.20A | 2ya7B-2bf6A:56.7 | 2ya7B-2bf6A:43.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2YA7_C_ZMRC1776_1 (NEURAMINIDASE A) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 5 / 12 | ARG A 266ILE A 267ASP A 283ILE A 297ARG A 615 | SIA A1692 (-2.7A)SIA A1692 (-4.5A)NoneNoneSIA A1692 (-3.1A) | 1.36A | 2ya7C-2bf6A:52.3 | 2ya7C-2bf6A:43.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2YA7_C_ZMRC1776_1 (NEURAMINIDASE A) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 9 / 12 | ARG A 266ILE A 267ASP A 283ILE A 327ASP A 328TYR A 485ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 (-4.5A)NoneSIA A1692 (-4.5A)SIA A1692 (-2.9A)SIA A1692 (-4.7A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.34A | 2ya7C-2bf6A:52.3 | 2ya7C-2bf6A:43.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2YA7_C_ZMRC1776_2 (NEURAMINIDASE A) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 4 / 6 | ASP A 291GLN A 493GLU A 539TYR A 587 | SIA A1692 (-2.8A)SIA A1692 (-3.0A)SIA A1692 ( 3.9A)None | 0.28A | 2ya7C-2bf6A:52.3 | 2ya7C-2bf6A:43.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2YA7_D_ZMRD1776_1 (NEURAMINIDASE A) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 5 / 12 | ARG A 266ILE A 267ASP A 283ILE A 297ARG A 615 | SIA A1692 (-2.7A)SIA A1692 (-4.5A)NoneNoneSIA A1692 (-3.1A) | 1.38A | 2ya7D-2bf6A:56.6 | 2ya7D-2bf6A:43.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2YA7_D_ZMRD1776_1 (NEURAMINIDASE A) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 10 / 12 | ARG A 266ILE A 267ASP A 283ILE A 327ASP A 328TYR A 485GLN A 493ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 (-4.5A)NoneSIA A1692 (-4.5A)SIA A1692 (-2.9A)SIA A1692 (-4.7A)SIA A1692 (-3.0A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.35A | 2ya7D-2bf6A:56.6 | 2ya7D-2bf6A:43.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2YA7_D_ZMRD1776_1 (NEURAMINIDASE A) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 5 / 12 | ARG A 285ILE A 267ASP A 328TYR A 485GLN A 493 | SIA A1692 (-3.6A)SIA A1692 (-4.5A)SIA A1692 (-2.9A)SIA A1692 (-4.7A)SIA A1692 (-3.0A) | 1.20A | 2ya7D-2bf6A:56.6 | 2ya7D-2bf6A:43.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZIA_B_CL9B401_2 (DEOXYCYTIDINE KINASE) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 4 / 4 | ARG A 266ASP A 283LEU A 669ARG A 555 | SIA A1692 (-2.7A)NoneNoneSIA A1692 (-2.9A) | 1.36A | 2ziaB-2bf6A:undetectable | 2ziaB-2bf6A:20.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3B7E_A_ZMRA1001_1 (NEURAMINIDASE) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 6 / 12 | ARG A 266ASP A 291GLU A 539ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 (-2.8A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.58A | 3b7eA-2bf6A:21.3 | 3b7eA-2bf6A:19.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3B7E_B_ZMRB1002_1 (NEURAMINIDASE) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 6 / 12 | ARG A 266ASP A 291GLU A 539ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 (-2.8A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.57A | 3b7eB-2bf6A:21.4 | 3b7eB-2bf6A:19.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3BRF_A_SORA2_0 (LIN-12 AND GLP-1PHENOTYPE PROTEIN 1,ISOFORM A) |
4jtv | HEMAGGLUTININ (InfluenzaAvirus) | 3 / 3 | LYS A 148LYS A 136VAL A 138 | SIA A 605 (-3.3A)NoneNone | 0.70A | 3brfA-4jtvA:undetectable | 3brfA-4jtvA:20.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3CKZ_A_ZMRA469_1 (NEURAMINIDASE) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 5 / 12 | ARG A 266GLU A 539ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.43A | 3ckzA-2bf6A:12.9 | 3ckzA-2bf6A:20.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3K37_B_BCZB468_0 (NEURAMINIDASE) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 5 / 12 | ARG A 266ASP A 291GLU A 539ARG A 555ARG A 615 | SIA A1692 (-2.7A)SIA A1692 (-2.8A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-3.1A) | 0.54A | 3k37B-2bf6A:24.9 | 3k37B-2bf6A:22.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3K39_B_BCZB1001_0 (NEURAMINIDASE) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 5 / 12 | ARG A 266ASP A 291GLU A 539ARG A 555TYR A 655 | SIA A1692 (-2.7A)SIA A1692 (-2.8A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-4.2A) | 0.43A | 3k39B-2bf6A:24.9 | 3k39B-2bf6A:22.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3SAN_A_ZMRA901_1 (NEURAMINIDASE) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 5 / 12 | ARG A 266GLU A 539ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.43A | 3sanA-2bf6A:4.4 | 3sanA-2bf6A:22.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3SAN_B_ZMRB901_1 (NEURAMINIDASE) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 5 / 12 | ARG A 266GLU A 539ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.43A | 3sanB-2bf6A:22.1 | 3sanB-2bf6A:22.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TI5_A_ZMRA1002_1 (NEURAMINIDASE) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 6 / 12 | ARG A 266ASP A 291GLU A 539ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 (-2.8A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.53A | 3ti5A-2bf6A:12.5 | 3ti5A-2bf6A:21.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TI5_B_ZMRB1002_1 (NEURAMINIDASE) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 6 / 12 | ARG A 266ASP A 291GLU A 539ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 (-2.8A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.55A | 3ti5B-2bf6A:21.4 | 3ti5B-2bf6A:21.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TIC_A_ZMRA1002_1 (NEURAMINIDASE) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 6 / 12 | ARG A 266ASP A 291GLU A 539ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 (-2.8A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.49A | 3ticA-2bf6A:8.6 | 3ticA-2bf6A:23.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TIC_B_ZMRB1002_1 (NEURAMINIDASE) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 6 / 12 | ARG A 266ASP A 291GLU A 539ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 (-2.8A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.53A | 3ticB-2bf6A:21.4 | 3ticB-2bf6A:23.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TIC_C_ZMRC1002_1 (NEURAMINIDASE) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 6 / 12 | ARG A 266ASP A 291GLU A 539ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 (-2.8A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.50A | 3ticC-2bf6A:8.9 | 3ticC-2bf6A:23.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TIC_D_ZMRD1002_1 (NEURAMINIDASE) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 6 / 12 | ARG A 266ASP A 291GLU A 539ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 (-2.8A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.50A | 3ticD-2bf6A:21.3 | 3ticD-2bf6A:23.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UA5_B_06XB501_1 (CYTOCHROME P450 2B6) |
2v73 | PUTATIVEEXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 4 / 7 | ILE A 40ILE A 110SER A 53GLU A 79 | NoneNoneNoneSIA A1190 (-3.1A) | 0.59A | 3ua5B-2v73A:undetectable | 3ua5B-2v73A:18.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UA5_B_06XB501_1 (CYTOCHROME P450 2B6) |
5fre | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 4 / 7 | ILE A 35ILE A 111SER A 48GLU A 74 | NoneNoneNoneSIA A 201 (-3.1A) | 0.64A | 3ua5B-5freA:undetectable | 3ua5B-5freA:20.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3VLN_A_ASCA904_0 (GLUTATHIONES-TRANSFERASEOMEGA-1) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 4 / 6 | ARG A 615LEU A 590PRO A 610GLU A 585 | SIA A1692 (-3.1A)NoneNoneNone | 1.19A | 3vlnA-2bf6A:undetectable | 3vlnA-2bf6A:20.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4A3U_A_NCAA1359_0 (NADH:FLAVINOXIDOREDUCTASE/NADHOXIDASE) |
5m63 | H CHAIN OF FABNVS-1-19-5L CHAIN OF FABNVS-1-19-5 (Oryctolaguscuniculus;Oryctolaguscuniculus) | 4 / 7 | THR L 123TRP H 65HIS H 127ASN L 118 | NoneNoneSIA H 306 ( 3.7A)None | 1.24A | 4a3uA-5m63L:undetectable | 4a3uA-5m63L:21.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4AE1_A_NCAA1536_0 (DIPHTHERIA TOXIN) |
6er3 | BNR/ASP-BOX REPEATPROTEIN ([Ruminococcus]gnavus) | 4 / 6 | GLY A 160TYR A 75TYR A 169GLU A 85 | NoneSIA A 201 ( 4.4A)NoneSIA A 201 (-3.1A) | 1.00A | 4ae1A-6er3A:undetectable | 4ae1A-6er3A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4B7N_A_ZMRA601_1 (NEURAMINIDASE) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 6 / 12 | ARG A 266ASP A 291GLU A 539ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 (-2.8A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.57A | 4b7nA-2bf6A:21.3 | 4b7nA-2bf6A:21.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4B7Q_A_ZMRA601_1 (NEURAMINIDASE) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 6 / 12 | ARG A 266ASP A 291GLU A 539ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 (-2.8A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.65A | 4b7qA-2bf6A:21.4 | 4b7qA-2bf6A:21.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4B7Q_B_ZMRB601_1 (NEURAMINIDASE) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 6 / 12 | ARG A 266ASP A 291GLU A 539ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 (-2.8A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.61A | 4b7qB-2bf6A:21.3 | 4b7qB-2bf6A:21.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4B7Q_C_ZMRC601_1 (NEURAMINIDASE) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 6 / 12 | ARG A 266ASP A 291GLU A 539ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 (-2.8A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.57A | 4b7qC-2bf6A:21.2 | 4b7qC-2bf6A:21.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4B7Q_D_ZMRD601_1 (NEURAMINIDASE) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 6 / 12 | ARG A 266ASP A 291GLU A 539ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 (-2.8A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.64A | 4b7qD-2bf6A:12.5 | 4b7qD-2bf6A:21.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPN_A_ZMRA700_1 (NEURAMINIDASE) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 6 / 12 | ARG A 266ASP A 291GLU A 539ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 (-2.8A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.54A | 4cpnA-2bf6A:24.9 | 4cpnA-2bf6A:23.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPN_B_ZMRB700_1 (NEURAMINIDASE) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 6 / 12 | ARG A 266ASP A 291GLU A 539ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 (-2.8A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.54A | 4cpnB-2bf6A:25.1 | 4cpnB-2bf6A:23.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_A_ZMRA1471_1 (NEURAMINIDASE) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 5 / 12 | ARG A 266GLU A 539ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.39A | 4cpzA-2bf6A:25.0 | 4cpzA-2bf6A:23.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_B_ZMRB1471_1 (NEURAMINIDASE) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 5 / 12 | ARG A 266GLU A 539ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.36A | 4cpzB-2bf6A:25.0 | 4cpzB-2bf6A:23.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_C_ZMRC1470_1 (NEURAMINIDASE) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 6 / 12 | ARG A 266ASP A 291GLU A 539ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 (-2.8A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.55A | 4cpzC-2bf6A:5.8 | 4cpzC-2bf6A:23.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_D_ZMRD1471_1 (NEURAMINIDASE) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 5 / 12 | ARG A 266GLU A 539ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.33A | 4cpzD-2bf6A:25.0 | 4cpzD-2bf6A:23.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_E_ZMRE1471_1 (NEURAMINIDASE) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 6 / 12 | ARG A 266ASP A 291GLU A 539ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 (-2.8A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.58A | 4cpzE-2bf6A:25.0 | 4cpzE-2bf6A:23.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_F_ZMRF1470_1 (NEURAMINIDASE) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 6 / 12 | ARG A 266ASP A 291GLU A 539ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 (-2.8A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.56A | 4cpzF-2bf6A:24.9 | 4cpzF-2bf6A:23.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_G_ZMRG1471_1 (NEURAMINIDASE) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 6 / 12 | ARG A 266ASP A 291GLU A 539ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 (-2.8A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.50A | 4cpzG-2bf6A:25.1 | 4cpzG-2bf6A:23.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_H_ZMRH1470_1 (NEURAMINIDASE) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 6 / 12 | ARG A 266ASP A 291GLU A 539ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 (-2.8A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.57A | 4cpzH-2bf6A:24.9 | 4cpzH-2bf6A:23.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4EQ4_A_SALA601_1 (4-SUBSTITUTEDBENZOATES-GLUTAMATELIGASE GH3.12) |
5xl6 | HEMAGGLUTININ (InfluenzaAvirus) | 4 / 7 | LEU A 191TYR A 192ILE A 249GLY A 130 | SIA A 603 (-4.7A)NoneNoneSIA A 603 ( 4.4A) | 0.93A | 4eq4A-5xl6A:undetectable | 4eq4A-5xl6A:20.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4EQL_A_SALA602_1 (4-SUBSTITUTEDBENZOATES-GLUTAMATELIGASE GH3.12) |
5xl6 | HEMAGGLUTININ (InfluenzaAvirus) | 4 / 7 | LEU A 191TYR A 192ILE A 249GLY A 130 | SIA A 603 (-4.7A)NoneNoneSIA A 603 ( 4.4A) | 0.93A | 4eqlA-5xl6A:undetectable | 4eqlA-5xl6A:20.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4EQL_B_SALB602_1 (4-SUBSTITUTEDBENZOATES-GLUTAMATELIGASE GH3.12) |
5xl6 | HEMAGGLUTININ (InfluenzaAvirus) | 4 / 7 | LEU A 191TYR A 192ILE A 249GLY A 130 | SIA A 603 (-4.7A)NoneNoneSIA A 603 ( 4.4A) | 0.95A | 4eqlB-5xl6A:undetectable | 4eqlB-5xl6A:20.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FGZ_B_CQAB301_0 (PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE) |
5xl6 | HEMAGGLUTININ (InfluenzaAvirus) | 4 / 8 | GLY A 215GLY A 225GLU A 187LEU A 223 | NoneSIA A 603 ( 4.4A)SIA A 603 (-3.1A)SIA A 603 (-4.3A) | 0.88A | 4fgzB-5xl6A:undetectable | 4fgzB-5xl6A:22.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4I00_A_ZMRA509_1 (NEURAMINIDASE) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 6 / 12 | ARG A 266ASP A 291GLU A 539ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 (-2.8A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.49A | 4i00A-2bf6A:21.7 | 4i00A-2bf6A:21.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4L39_A_SALA602_1 (4-SUBSTITUTEDBENZOATES-GLUTAMATELIGASE GH3.12) |
5xl6 | HEMAGGLUTININ (InfluenzaAvirus) | 4 / 6 | LEU A 191TYR A 192ILE A 249GLY A 130 | SIA A 603 (-4.7A)NoneNoneSIA A 603 ( 4.4A) | 0.91A | 4l39A-5xl6A:undetectable | 4l39A-5xl6A:20.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4L39_B_SALB601_1 (4-SUBSTITUTEDBENZOATES-GLUTAMATELIGASE GH3.12) |
5xl6 | HEMAGGLUTININ (InfluenzaAvirus) | 4 / 7 | LEU A 191TYR A 192ILE A 249GLY A 130 | SIA A 603 (-4.7A)NoneNoneSIA A 603 ( 4.4A) | 0.90A | 4l39B-5xl6A:undetectable | 4l39B-5xl6A:20.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 4 / 7 | TYR A 485ILE A 498ILE A 509ALA A 496 | SIA A1692 (-4.7A)NoneNoneNone | 0.87A | 4lv9A-2bf6A:undetectable | 4lv9A-2bf6A:22.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MWR_A_ZMRA513_1 (NEURAMINIDASE) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 5 / 12 | ARG A 266GLU A 539ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.44A | 4mwrA-2bf6A:21.2 | 4mwrA-2bf6A:22.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MWX_A_ZMRA513_1 (NEURAMINIDASE) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 5 / 12 | ARG A 266ASP A 291GLU A 539ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 (-2.8A)SIA A1692 ( 3.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.53A | 4mwxA-2bf6A:21.3 | 4mwxA-2bf6A:22.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MX0_A_BCZA513_1 (NEURAMINIDASE) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 3 / 3 | ARG A 266ASP A 291ARG A 615 | SIA A1692 (-2.7A)SIA A1692 (-2.8A)SIA A1692 (-3.1A) | 0.47A | 4mx0A-2bf6A:9.2 | 4mx0A-2bf6A:22.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4PEV_C_ADNC501_2 (MEMBRANE LIPOPROTEINFAMILY PROTEIN) |
1sie | POLYOMAVIRUS COATPROTEIN VP1 (Musmusculuspolyomavirus1) | 3 / 3 | PRO A 144VAL A 290HIS A 298 | NoneNoneSIA A 384 (-3.6A) | 0.83A | 4pevC-1sieA:undetectable | 4pevC-1sieA:23.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4WA5_A_ZMRA501_1 (NEURAMINIDASE) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 6 / 12 | ARG A 266ASP A 291GLU A 539ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 (-2.8A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.68A | 4wa5A-2bf6A:10.2 | 4wa5A-2bf6A:21.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4WNU_C_QDNC602_1 (CYTOCHROME P450 2D6) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 5 / 11 | GLY A 462GLU A 539PHE A 347ALA A 292ASP A 291 | NoneSIA A1692 ( 3.9A)NoneNoneSIA A1692 (-2.8A) | 1.37A | 4wnuC-2bf6A:undetectable | 4wnuC-2bf6A:21.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4X5J_A_FOLA201_0 (DIHYDROFOLATEREDUCTASE) |
4rco | PUTATIVEUNCHARACTERIZEDPROTEIN (Staphylococcusaureus) | 5 / 12 | ILE A 300LEU A 242ILE A 268ARG A 250ILE A 303 | NoneSIA A 404 (-4.9A)NoneNoneNone | 1.05A | 4x5jA-4rcoA:undetectable | 4x5jA-4rcoA:19.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YHA_C_MZMC303_1 (ALPHA-CARBONICANHYDRASE) |
1mco | IGG1 MCG INTACTANTIBODY (HEAVYCHAIN) (Homosapiens) | 5 / 11 | ASP H 265VAL H 264VAL H 269LEU H 291THR H 292 | NoneNoneNoneNoneSIA H 436 (-4.0A) | 1.42A | 4yhaC-1mcoH:undetectable | 4yhaC-1mcoH:19.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5CU6_A_ACTA403_0 (CASEIN KINASE IISUBUNIT ALPHA) |
5wht | PUTATIVEPERTUSSIS-LIKE TOXINSUBUNIT (Salmonellaenterica) | 4 / 6 | TYR A 34ILE A 55VAL A 103ALA A 69 | SIA A 201 ( 4.2A)NoneNoneNone | 0.90A | 5cu6A-5whtA:undetectable | 5cu6A-5whtA:20.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5D0Y_A_FOLA201_0 (CONSERVEDHYPOTHETICALMEMBRANE PROTEIN) |
5fre | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 5 / 12 | LEU A 109ASN A 122TYR A 65VAL A 37HIS A 93 | NoneNoneSIA A 201 (-4.0A)NoneSIA A 201 ( 4.8A) | 1.41A | 5d0yA-5freA:undetectable | 5d0yA-5freA:21.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5D0Y_B_FOLB201_0 (CONSERVEDHYPOTHETICALMEMBRANE PROTEIN) |
5fre | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 5 / 12 | LEU A 109ASN A 122TYR A 65VAL A 37HIS A 93 | NoneNoneSIA A 201 (-4.0A)NoneSIA A 201 ( 4.8A) | 1.41A | 5d0yB-5freA:undetectable | 5d0yB-5freA:21.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5L17_A_ZMRA512_1 (NEURAMINIDASE) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 6 / 12 | ARG A 266ASP A 291GLU A 539ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 (-2.8A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.49A | 5l17A-2bf6A:21.1 | 5l17A-2bf6A:23.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5N5D_A_SAMA306_1 (METHYLTRANSFERASE) |
2wbv | FIBER PROTEIN (CaninemastadenovirusA) | 4 / 7 | LEU A 512PHE A 514SER A 419ILE A 477 | NoneNoneSIA A1545 (-4.4A)None | 1.06A | 5n5dA-2wbvA:undetectable | 5n5dA-2wbvA:20.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5X7P_A_ACRA1401_2 (GLYCOSIDE HYDROLASEFAMILY 31ALPHA-GLUCOSIDASE) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 5 / 9 | GLN A 536GLN A 493ILE A 267GLY A 559SER A 558 | NoneSIA A1692 (-3.0A)SIA A1692 (-4.5A)NoneNone | 1.31A | 5x7pB-2bf6A:0.9 | 5x7pB-2bf6A:16.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5X7P_B_ACRB1401_1 (GLYCOSIDE HYDROLASEFAMILY 31ALPHA-GLUCOSIDASE) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 5 / 9 | GLN A 536GLN A 493ILE A 267GLY A 559SER A 558 | NoneSIA A1692 (-3.0A)SIA A1692 (-4.5A)NoneNone | 1.38A | 5x7pA-2bf6A:1.4 | 5x7pA-2bf6A:16.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XDH_C_DAHC60_1 (PUTATIVE CYTOCHROMEC) |
4d63 | FIBER KNOB DOMAIN (TurkeysiadenovirusA) | 4 / 6 | MET A 427ASN A 422VAL A 420LEU A 418 | NoneSIA A1455 (-4.5A)SIA A1455 (-4.4A)None | 1.14A | 5xdhA-4d63A:undetectable5xdhC-4d63A:undetectable | 5xdhA-4d63A:22.395xdhC-4d63A:22.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Z84_J_CHDJ101_0 (CYTOCHROME C OXIDASESUBUNIT 7A1,MITOCHONDRIAL) |
4en8 | HEMAGGLUTININCOMPONENTSHA-22/23/53 (Clostridiumbotulinum) | 3 / 3 | TYR B 536ARG B 525THR B 508 | NoneSIA B 701 (-3.0A)None | 0.73A | 5z84J-4en8B:undetectable | 5z84J-4en8B:9.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6EKU_A_ZMRA901_1 (SIALIDASE) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 7 / 12 | ARG A 266ILE A 267ARG A 285GLU A 539ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 (-4.5A)SIA A1692 (-3.6A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.39A | 6ekuA-2bf6A:44.2 | 6ekuA-2bf6A:23.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6EKU_A_ZMRA901_1 (SIALIDASE) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 7 / 12 | ARG A 266ILE A 267ASP A 328GLU A 539ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 (-4.5A)SIA A1692 (-2.9A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.67A | 6ekuA-2bf6A:44.2 | 6ekuA-2bf6A:23.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6F6S_A_CXQA507_1 (ENVELOPEGLYCOPROTEIN,ENVELOPE GLYCOPROTEIN,GP1ENVELOPEGLYCOPROTEIN) |
4nfd | PAIREDIMMUNOGLOBULIN-LIKETYPE 2 RECEPTOR BETA (Homosapiens) | 4 / 5 | ARG A 96TYR A 3GLN A 110ILE A 112 | SIA A 201 (-3.0A)SIA A 201 (-3.4A)NoneNone | 1.25A | 6f6sA-4nfdA:undetectable6f6sB-4nfdA:undetectable | 6f6sA-4nfdA:20.836f6sB-4nfdA:20.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6HCX_A_ZMRA519_0 (NEURAMINIDASE) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 5 / 12 | ARG A 266ASP A 291ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 (-2.8A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.53A | 6hcxA-2bf6A:21.2 | 6hcxA-2bf6A:10.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MHT_D_SAMD328_0 (CYTOSINE-SPECIFICMETHYLTRANSFERASEHHAI) |
2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) | 5 / 12 | GLY A 466ASP A 328ILE A 498SER A 591VAL A 592 | NoneSIA A1692 (-2.9A)NoneNoneNone | 1.11A | 6mhtA-2bf6A:undetectable | 6mhtA-2bf6A:22.78 |